It was revealed that the binding of GZMA to the LDPRSFLL motif at the N-terminus of F2R promotes apoptosis via JAK2/STAT1 signaling, which in synergy with the PD-1 mAb therapy led to tumor suppression in both mouse model and HCC patients (Fig. S12). Here, JAK2 is linked to hepatocellular carcinoma.